Annual D&A
N/A
December 1, 2024
Summary
- VKTX annual depreciation & amortization is not available.
Performance
VKTX Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
Quarterly D&A
N/A
December 1, 2024
Summary
- VKTX quarterly depreciation & amortization is not available.
Performance
VKTX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM D&A
N/A
December 1, 2024
Summary
- VKTX TTM depreciation & amortization is not available.
Performance
VKTX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
VKTX Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
VKTX Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time |
Viking Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $87.00 K(+16.0%) | $310.00 K(+4.7%) |
| Jun 2024 | - | $75.00 K(+1.4%) | $296.00 K(+0.7%) |
| Mar 2024 | - | $74.00 K(0.0%) | $294.00 K(+0.7%) |
| Dec 2023 | $292.00 K(+0.3%) | $74.00 K(+1.4%) | $292.00 K(+0.7%) |
| Sep 2023 | - | $73.00 K(0.0%) | $290.00 K(-19.2%) |
| Jun 2023 | - | $73.00 K(+1.4%) | $359.00 K(+25.5%) |
| Mar 2023 | - | $72.00 K(0.0%) | $286.00 K(-1.7%) |
| Dec 2022 | $291.00 K(-1.7%) | $72.00 K(-49.3%) | $291.00 K(-1.4%) |
| Sep 2022 | - | $142.00 K(>+9900.0%) | $295.00 K(+29.4%) |
| Jun 2022 | - | $0.00(-100.0%) | $228.00 K(-24.3%) |
| Mar 2022 | - | $77.00 K(+1.3%) | $301.00 K(+1.7%) |
| Dec 2021 | $296.00 K | $76.00 K(+1.3%) | $296.00 K(+1.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $75.00 K(+2.7%) | $291.00 K(+1.7%) |
| Jun 2021 | - | $73.00 K(+1.4%) | $286.00 K(+1.8%) |
| Mar 2021 | - | $72.00 K(+1.4%) | $281.00 K(+1.4%) |
| Dec 2020 | $277.00 K(+6.5%) | $71.00 K(+1.4%) | $277.00 K(+1.8%) |
| Sep 2020 | - | $70.00 K(+2.9%) | $272.00 K(+1.5%) |
| Jun 2020 | - | $68.00 K(0.0%) | $268.00 K(+1.5%) |
| Mar 2020 | - | $68.00 K(+3.0%) | $264.00 K(+1.5%) |
| Dec 2019 | $260.00 K(>+9900.0%) | $66.00 K(0.0%) | $260.00 K(+34.0%) |
| Sep 2019 | - | $66.00 K(+3.1%) | $194.00 K(+51.6%) |
| Jun 2019 | - | $64.00 K(0.0%) | $128.00 K(+100.0%) |
| Mar 2019 | - | $64.00 K | $64.00 K |
| Dec 2018 | $0.00 | - | - |
FAQ
- What is the all time high annual D&A for Viking Therapeutics?
- What is the all time high quarterly D&A for Viking Therapeutics?
- What is the all time high TTM D&A for Viking Therapeutics?
What is the all time high annual D&A for Viking Therapeutics?
Viking Therapeutics all-time high annual depreciation & amortization is $296.00 K
What is the all time high quarterly D&A for Viking Therapeutics?
Viking Therapeutics all-time high quarterly depreciation & amortization is $142.00 K
What is the all time high TTM D&A for Viking Therapeutics?
Viking Therapeutics all-time high TTM depreciation & amortization is $359.00 K